Back
Perspective Therapeutics Stock Price Chart
The little-known AI stock you need to read about now...
Get the name - FREE.
Buy
77
CATX
Perspective Therapeutics
Last Price:
1.69
Seasonality Move:
1.64%
7 Day Trial
ALL ACCESS PASS
$
7
Elon's Secret "A.I. 2.0" Project
Click here now to discover how to claim a stake in Elon's "A.I. 2.0" project- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CATX is experiencing slight buying pressure.
Perspective Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.56 | Buy |
| 20-day SMA: | 1.5 | Buy |
| 50-day SMA: | 1.24 | Buy |
| 200-day SMA: | 0.62 | Buy |
| 8-day EMA: | 1.58 | Buy |
| 20-day EMA: | 1.48 | Buy |
| 50-day EMA: | 1.26 | Buy |
| 200-day EMA: | 0.78 | Buy |
Perspective Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 60.72 | Buy |
| Chaikin Money Flow: | 468963 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.31 - 1.59) | Buy |
| Bollinger Bands (100): | (0.46 - 1.3) | Buy |
Perspective Therapeutics Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Perspective Therapeutics Stock
Is Perspective Therapeutics Stock a Buy?
- Perspective Therapeutics share price is 1.58 while CATX 8-day simple moving average is 1.56, which is a Buy signal.
- The stock price of CATX is 1.58 while Perspective Therapeutics 20-day SMA is 1.50, which makes it a Buy.
- Perspective Therapeutics 50-day simple moving average is 1.24 while CATX share price is 1.58, making it a Buy technically.
- CATX stock price is 1.58 and Perspective Therapeutics 200-day simple moving average is 0.62, creating a Buy signal.
CATX Technical Analysis vs Fundamental Analysis
Buy
77
Perspective Therapeutics (CATX)
is a Buy
Is Perspective Therapeutics a Buy or a Sell?
-
Perspective Therapeutics stock is rated a Buy
The current Perspective Therapeutics [CATX] share price is $1.58. The Score for CATX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
Perspective Therapeutics Stock Info
Market Cap:
927.33M
Price in USD:
1.58
Share Volume:
4.68M
Perspective Therapeutics 52-Week Range
52-Week High:
1.77
52-Week Low:
0.21
Buy
77
Perspective Therapeutics (CATX)
is a Buy
Perspective Therapeutics Share Price Forecast
-
What is the Perspective Therapeutics stock price today?
The Perspective Therapeutics stock price is 1.58 USD today. -
Will CATX stock go up or go down?
Perspective Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Perspective Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Perspective Therapeutics is not overvalued.
Is Perspective Therapeutics Stock a Buy?
- Perspective Therapeutics share price is 1.58 while CATX 8-day exponential moving average is 1.58, which is a Buy signal.
- The stock price of CATX is 1.58 while Perspective Therapeutics 20-day EMA is 1.48, which makes it a Buy.
- Perspective Therapeutics 50-day exponential moving average is 1.26 while CATX share price is 1.58, making it a Buy technically.
- CATX stock price is 1.58 and Perspective Therapeutics 200-day simple moving average is 0.78, creating a Buy signal.
Fundamental Analysis of Perspective Therapeutics
Is Perspective Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Perspective Therapeutics
Should I short Perspective Therapeutics stock?
- CATX Moving Average Covergence Divergence (MACD) indicator is 0.11, suggesting Perspective Therapeutics is a Buy
- Perspective Therapeutics Relative Strength Index (RSI) is 60.72, which suggest Perspective Therapeutics is overbought
- The Bollinger Bands (25) for Perspective Therapeutics is (1.31 - 1.59), which suggest Perspective Therapeutics is a Buy
- The Bollinger Bands (100) for Perspective Therapeutics is (0.46 - 1.3), which suggest Perspective Therapeutics is a Buy
* Perspective Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.